Back
Neurocrine Biosciences Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
57
NBIX
Neurocrine Biosciences
Last Price:
126.74
Seasonality Move:
17.1%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBIX is experiencing slight selling pressure.
Neurocrine Biosciences Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 122.06 | Buy |
| 20-day SMA: | 122.35 | Buy |
| 50-day SMA: | 118.69 | Buy |
| 200-day SMA: | 133.44 | Sell |
| 8-day EMA: | 123.06 | Buy |
| 20-day EMA: | 121.92 | Buy |
| 50-day EMA: | 122.46 | Buy |
| 200-day EMA: | 127.9 | Sell |
Neurocrine Biosciences Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.09 | Buy |
| Relative Strength Index (14 RSI): | 58.45 | Buy |
| Chaikin Money Flow: | -36833 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (117.05 - 125.11) | Buy |
| Bollinger Bands (100): | (116.14 - 144.06) | Sell |
Neurocrine Biosciences Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Neurocrine Biosciences Stock
Is Neurocrine Biosciences Stock a Buy?
- Neurocrine Biosciences share price is 125.65 while NBIX 8-day simple moving average is 122.06, which is a Buy signal.
- The stock price of NBIX is 125.65 while Neurocrine Biosciences 20-day SMA is 122.35, which makes it a Buy.
- Neurocrine Biosciences 50-day simple moving average is 118.69 while NBIX share price is 125.65, making it a Buy technically.
- NBIX stock price is 125.65 and Neurocrine Biosciences 200-day simple moving average is 133.44, creating a Sell signal.
NBIX Technical Analysis vs Fundamental Analysis
Buy
57
Neurocrine Biosciences (NBIX)
is a Buy
Is Neurocrine Biosciences a Buy or a Sell?
-
Neurocrine Biosciences stock is rated a Buy
The current Neurocrine Biosciences [NBIX] share price is $125.65. The Score for NBIX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
Neurocrine Biosciences Stock Info
Market Cap:
12.72B
Price in USD:
125.65
Share Volume:
1.21M
Neurocrine Biosciences 52-Week Range
52-Week High:
157.98
52-Week Low:
110.52
Buy
57
Neurocrine Biosciences (NBIX)
is a Buy
Neurocrine Biosciences Share Price Forecast
-
What is the Neurocrine Biosciences stock price today?
The Neurocrine Biosciences stock price is 125.65 USD today. -
Will NBIX stock go up or go down?
Neurocrine Biosciences> share price is forecast to RISE/FALL based on technical indicators -
Is Neurocrine Biosciences overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Neurocrine Biosciences is not overvalued.
Is Neurocrine Biosciences Stock a Buy?
- Neurocrine Biosciences share price is 125.65 while NBIX 8-day exponential moving average is 123.06, which is a Buy signal.
- The stock price of NBIX is 125.65 while Neurocrine Biosciences 20-day EMA is 121.92, which makes it a Buy.
- Neurocrine Biosciences 50-day exponential moving average is 122.46 while NBIX share price is 125.65, making it a Buy technically.
- NBIX stock price is 125.65 and Neurocrine Biosciences 200-day simple moving average is 127.90, creating a Sell signal.
Fundamental Analysis of Neurocrine Biosciences
Is Neurocrine Biosciences a good investment?
- Analysts estimate an earnings increase this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.44 per share, and an increase next year of $1.13 per share.
Technical Analysis of Neurocrine Biosciences
Should I short Neurocrine Biosciences stock?
- NBIX Moving Average Covergence Divergence (MACD) indicator is 1.09, suggesting Neurocrine Biosciences is a Buy
- Neurocrine Biosciences Relative Strength Index (RSI) is 58.45, which suggest Neurocrine Biosciences is overbought
- The Bollinger Bands (25) for Neurocrine Biosciences is (117.05 - 125.11), which suggest Neurocrine Biosciences is a Sell
- The Bollinger Bands (100) for Neurocrine Biosciences is (116.14 - 144.06), which suggest Neurocrine Biosciences is a Sell
* Neurocrine Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.